Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical study evaluating the safety and efficacy of GT729 Universal Cell Injection for refractory or relapsed chronic graft-versus-host disease is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• GT729 Universal Cell Injection

Snippet

Sponsor: Grit Biotechnology | Conditions: cGVHD | EARLY_Phase 1 | Status: RECRUITING